Introduction
D-lactic acidosis as a disease of humans was first described in 1979 [51] , although it had been known as a disease of ruminants for decades [22] . Following this initial report, numerous other cases of this syndrome have been described [6, 8, 13, 16, 24, 28, 29, 31, 33, 35, 36, 37, 39, 40, 41, 45, 46, 48, 49, 54, 55, 58, 59, 60, 61, 63, 64, 67] . The clinical presentation is characterized by episodes of encephalopathy and metabolic acidosis which are thought to be due to the absorption of d-lactic acid and other unidentified chemicals produced by bacterial fermentation in the colon. Initially d-lactic acidosis was thought to be due solely to overproduction of d-lactic acid because it was thought that d-lactic acid was not metabolized by humans [64] . The subsequent finding that normal subjects have an enormous capacity to metabolize d-lactic acid suggests, however, that the development of d-lactic acidosis requires impaired ability to metabolize d-lactic acid in addition to excessive production [52] .
In this report we present a case of d-lactic acidosis previously reported by us [53] , followed by a review of other cases of d-lactic acidosis reported in the literature. The purpose of this review is to define the clinical and biochemical features of d-lactic acidosis, and ultimately to shed some light on the pathogenetic mechanism of the disease. Last, we review the literature dealing with the metabolism of d-lactic acid in humans to explore the possible role of impaired utilization of dlactic acid in the pathogenesis of d-lactic acidosis. Table 1 . Characteristics of 29 patients with d-lactic acidosis, from previous reports A description of renal function was given for 12 of the patients: in 8 patients the BUN was described as normal [13, 24, 36, 58, 64, 67] , 1 patient had moderate azotemia and a creatinine clearance of 30 mL/min [64] , 1 had a serum creatinine of 2.2 mg/dL [45] , and 2 patients had endstage renal disease and were receiving maintenance hemodialysis [33, 63] .
Illustrative Case
As seen in Table 2 , the neurologic abnormality that was present in every case was altered mental status. Other neurologic abnormalities were slurred speech, confusion, inability to concentrate, somnolence, hallucinations, clumsiness, weakness, ataxia, unsteady gait, nystagmus, excessive irritability, and abusive behavior. The attacks were episodic, lasting from a few hours to several days. Electroencephalograms during encephalopathic episodes showed bilateral, diffuse, high-voltage slow waves without focal abnormality, which normalized after attacks [8, 24, 51, 63] . Partial ptosis has been described during an attack in 1 patient [36] and asterixis in another patient [24] . The presence of d-lactate in the cerebrospinal fluid was reported in 2 patients; the levels were the same as the serum levels [40, 61] . Table 2 . Prevalence of neurologic symptoms and signs Symptoms were aggravated by excessive oral food intake and alleviated after caloric restriction [6, 31, 40, 46, 49, 54, 58, 61] . In fact, craving for and excessive consumption of carbohydrates have been noted in several reports [8, 40, 61] . In 1 patient, symptoms seem to have been precipitated by the use of medium-chain triglycerides [37] which have been recommended to improve the nutritional status in patients with the short bowel syndrome.
Acidosis was present in all patients, and it was of quite variable degree, as shown in Table 3 .
The average serum anion gap was increased, but some values were within the normal range. The Table 3 . Serum electrolytes corresponding to the lowest blood pH
In those cases in which bacteriologic analysis of fecal flora was performed, it showed almost without exception a marked predominance of Gram-positive anaerobic organisms including a variety of lactobacillus, bifidobacterium, and eubacterium, which have been shown to produce dlactate in vitro [6, 33, 35, 46, 54, 59, 63, 65] . Evidence for the production of d-lactate by intestinal bacteria is contained in a number of reports [6, 16, 35, 46, 54, 59, 64] . (Table 4) summarizes the information on metabolism of d-lactate by humans. The data show a substantial rate of metabolism of d-lactate [1, 11, 17, 18, 32, 42, 52, 72] . 
Discussion

Clinical manifestations
The characteristic manifestations of d-lactic acidosis are recurrent episodes of encephalopathy and metabolic acidosis occurring in a patient with the short bowel syndrome. Neurologic abnormalities are always present although their nature varies from patient to patient. Common features include slurred speech, confusion, inability to concentrate, somnolence, hallucinations, clumsiness, weakness, ataxia, unsteady gait, nystagmus, excessive irritability, and abusive behavior. These episodes last from a few hours to several days.
Metabolic acidosis is always present but its severity varies from patient to patient and for a given patient from 1 attack to another. The serum anion gap is usually high at the onset of symptoms but the increase in the anion gap tends to be less than the decrease in the serum bicarbonate concentration; in l-lactic acidosis the increase in the anion gap is usually greater than the reduction in bicarbonate [50] . The discrepancy could be explained by 2 factors: the significantly lower renal threshold for d-lactate (<1 mmol/L) than for l-lactate [52] , and the loss of the sodium salt of d-lactic acid in the stool (the H + , but not the organic anion is reabsorbed or reacts with secreted HCO 3 in the lumen) [30] . Moreover, these patients can have baseline hyperchloremic acidosis because of chronic diarrhea with loss of HCO 3 in the stool. One patient has been described [36] who might have had underlying renal acidification defects. Several patients have been reported [2, 19, 25, 56, 57] Small quantities of d-lactate may be found normally in the blood [4] and excreted in the urine [38] . This d-lactate is probably formed in the body through the methyl-glyoxal pathway [65] or within the gastrointestinal tract by bacterial fermentation [10] . Other potential sources of d-lactate are dietary intake [53] and administration for medical use. Humans ingest d-lactate frequently [53] ; fermented fruits and vegetables such as pickles, yogurt, and sauerkraut contain both l-and d-lactic acid. Lactated Ringer solution and peritoneal dialysate also contain racemic mixtures of both isomers in the same proportion. Recently, it has been suggested that the metabolism of propylene glycol, an agent frequently used in medications and food, can lead to generation of dlactate [9] .
The predominant form of lactate normally present in the blood of humans and other vertebrates is l-lactate, which is derived from pyruvate by the action of l-LDH.
Metabolism of d-lactate in humans and animals
When d-lactic acidosis was first described in humans in 1979 [51] it was thought that mammals metabolize d-lactate very slowly. It is now clear, however, through the evidence summarized in Table 4 , that normal humans metabolize d-lactate efficiently. The most complete data are those of Oh and colleagues [52] , who showed that normal subjects were able to metabolize d-lactate at a rate of 1.52 mmol/kg per hour with a serum level of 5.2 mmol/L, when dl-lactate was infused intravenously at a rate of 1.92 mmol/kg per hour for each isomer. At such a rate a person weighing 70 kg can metabolize about 2,500 mEq of d-lactate per day. These data are in agreement with those in other studies in humans [1, 11, 17, 18, 32, 42, 72] and in other mammals such as rats [26, 27] , rabbits [21] , dogs [14] , and baboons [12] . mammals lack a significant ability to metabolize d-lactate. However, a review of their data shows strong evidence that rats metabolize d-lactate efficiently; when d-lactate was given intravenously, it disappeared rapidly from the circulation and only 25% was excreted in the urine.
Moreover, ligation of renal arteries and veins did not alter the rate of elimination of d-lactate from the blood. Their data in a normal human subject have a number of inconsistencies. For example, while the total administered dose of d-lactate was 2.15 mmol, the plasma level was 1 mmol/L, an outcome that is impossible since the space of distribution of d-lactate should be at least equal to the extracellular space.
In summary, most of the data available in the literature strongly suggest that d-lactate is efficiently metabolized by mammals [1, 11, 12, 14, 17, 18, 21, 26, 27, 32, 42, 51, 72] . Since mammals lack d-LDH, metabolism of d-lactate must use alternative routes. The enzyme likely to be responsible for metabolism of d-lactate in mammals is d-2-hydroxy-acid-dehydrogenase, a mitochondrial enzyme that converts d-lactate to pyruvate and is found in a variety of animal tissues [7, 68] . This enzyme is a nonspecific flavoprotein, and its substrates include d-lactic acid as well as other d-2-hydroxy acids [20] . The enzyme may be important for the synthesis of protein and is active over only a limited pH range [20, 68] .
Renal handling of d-lactate
The renal threshold for d-lactate is much lower than that of l-lactate, and a significant proportion of d-lactate infused intravenously escapes in the urine [52] . Lactate is normally reabsorbed by a sodium-lactate contransporter, but it is not clear whether there are different transporters for each isomer or if the difference in reabsorption is the result of different rates of metabolism after reabsorption into the tubules [69] . The fact that l-and d-lactate compete with each other for renal tubular reabsorption suggests that they both utilize the same transporter [52] .
Pathogenesis of d-lactic acidosis
The syndrome of d-lactic acidosis is thought to be the result of the production and absorption of d-lactic acid from the intestine. D-lactic acid production results when carbohydrate malabsorption in the small bowel leads to increased delivery of carbohydrates to the colon with subsequent fermentation by colonic bacteria to l-and d-lactate. Only d-lactate accumulates because of its slower metabolism. An increased delivery of substrate to the colon is a constant finding in these patients. The latter point is clearly illustrated by the patient [49] who developed the syndrome following the accidental placement of a feeding tube directly into the colon; rapid reversal of the acidosis followed cessation of feeding and removal of the tube. The course of events described above has been clearly documented in d-lactic acidosis observed in ruminants overfed with grains [22] . In those cases it has been shown that acidosis is the result of the increased production of d-lactic acid by bacterial fermentation and its subsequent absorption into the blood. Large amounts of l-and d-lactic acid are produced by bacteria but only the d-isomer accumulates since absorbed l-lactic acid is more rapidly metabolized. When the rate of absorption of d-lactic acid into the body overwhelms the body's metabolic capacity to metabolize it, acidosis develops.
The presence of abnormal bacterial flora in the colon is also essential for the development of the syndrome. Stool cultures have invariably shown a marked predominance of Gram-positive anaerobes such as species of lactobacillus which are known to produce d-lactic acid in vitro.
Lactobacilli produce not only d-LDH but also dl-lactate racemase which could potentially explain interconversion of d-and l-lactate [35] . Alteration of the flora probably occurred following ingestion of lactobacillus in 1 case [51] and following antibiotic administration in 2 other cases [13, 24] .
Mild overproduction of d-lactic acid may not be unusual in patients with the short bowel syndrome. For example, Thurn et al [66] have shown that in a group of 33 patients with jejunoileal bypass, 9 (27%) patients had plasma d-lactate levels greater than 0.5 mmol/L (range, 0.7-11.5 mmol/L). Moreover, in 470 randomly chosen hospitalized patients, plasma d-lactate levels were greater than 0.5 mmol/L in 13, and 60% of these had a history of gastrointestinal surgery or disease. Hove et al [34] measured the fecal d-and l-lactate concentration in 100 nonselected patients at a referral center for gastrointestinal disorders and found that 21% had high d-lactate concentrations; the levels were high in 73% of the patients with active inflammatory bowel disease, in 33% of those with malabsorption syndrome, and in only 5% of patients with neither of these 2 conditions. Bustos et al [5] measured d-lactic acid in blood, urine, and fecess in 11 patients with the short bowel syndrome and showed that the levels in the stool were increased in 9 patients but that levels were undetectable in the urine in all 11 and in the blood of 10 of these patients (the lower limit of detection of d-lactic acid is not given). Bongaerts et al [3] studied a group of 8 patients with the short bowel syndrome and demonstrated that d-lactate is frequently present in serum and urine of these patients even in the absence of acidosis.
It is not known why d-lactic acidosis develops intermittently and not with every meal although the abnormal colonic flora, once developed, must be present constantly. If malabsorption syndrome with increased delivery of nutrients to the colon led immediately to osmotic diarrhea, there might not be a sufficient amount of substrate in the colon to produce clinical d-lactic acidosis. Hence, colonic stagnation might be another important contributing factor. The fact that the syndrome has not been described with greater frequency in patients with malabsorption syndrome not related to a short bowel may also be explained by the limited substrate availability in these other conditions. In general, malabsorption syndrome is more severe in the short bowel syndrome.
In vitro studies with stool homogenates have shown that the formation of d-lactic acid is stimulated by low pH and inhibited at pH 6.5 or higher [6] ; the suggestion has been made that increasing the luminal colonic pH by dietary supplements of CaCO 3 and MgCl 2 may potentially be used to diminish intestinal production of d-lactic acid [6] .
Another noteworthy point is the delay in the appearance of symptoms; patients with intestinal resection or bypass surgery usually develop d-lactic acidosis after a delay of several months to a few years. It has been suggested that a change in the intestinal flora occurs during this time [55] .
It is useful to estimate the likely rate of d-lactate production with usual food in order to determine whether a defect in d-lactate metabolism plays a role in the pathogenesis of d-lactic acidosis. For this estimation, we make the following assumptions. First, the daily caloric intake is 3,000 calories. Second, one-half of the calories ingested are absorbed in the small intestine and the other half delivered to the colon. Third, one-half of the daily caloric intake comes from 1 big meal such as dinner. Fourth, one-half of the entire caloric intake is in the form of carbohydrates.
Fifth, all the carbohydrates delivered to the colon are converted by bacteria to l-and d-lactate in equal proportions. In this case, if 1,500 calories are ingested during dinner, and 750 calories are delivered to the colon, 375 calories will be as carbohydrates and 375 as some other nutrients.
These 375 calories would come from 94 g of carbohydrates, which then would produce 522 mmol of d-lactate and 522 mmol of l-lactate. If we further assume that 522 mmol of d-lactate was produced over a 6-hour period, the production rate will be less than 100 mmol/hour. Since normal humans can metabolize d-lactate at a rate greater than 100 mmol/hour with modest increase in serum concentration [52] , one might argue that impaired metabolism is a prerequisite for the production of d-lactic acidosis.
On the other hand, it is also possible that d-lactic acidosis occurs only when the food intake is grossly excessive so that the rate of d-lactate production could exceed the rate estimated above.
It is also possible that the rate of d-lactate metabolism is reduced in these patients not because of any specific metabolic defect but as the result of generalized diminution in metabolism due to chronic malnutrition. If there is a specific mechanism of this impaired ability to metabolize dlactate, it is currently unknown. Metabolism of d-lactate in mammals seems to require d-2-hydroxy-acid-dehydrogenase, which converts d-lactate to pyruvate [7, 68] . This enzyme has been found in high concentrations in the liver and kidneys of several animal species including humans [72] , and it is possible that disease of these organs might diminish the ability to metabolize dlactate. For example, it has been shown that loading rats with d-lactate over several days significantly increased the activity of d-2-hydroxy-acid-dehydrogenase in the liver, but that this increase was much less in rats with chronic renal failure than in control animals [71] . Although renal function has been described in only a few patients with d-lactic acidosis, some degree of renal insufficiency is common because volume depletion and calcium oxalate kidney stones are frequent complications in patients with the short bowel syndrome. Unfortunately, the rate of metabolism of d-lactate in patients with d-lactic acidosis has not been measured.
Oxalate is a powerful competitive inhibitor of d-2-hydroxy-acid-dehydrogenase [68] . Patients with the short bowel syndrome frequently have intestinal hyperabsorption of oxalate, and it seems possible that high plasma and tissue levels of oxalate could inhibit enzyme activity. Low pH, which also diminishes the dehydrogenase activity [68] , could play a role in the diminished metabolism of d-lactate. The effect of pH on in vivo metabolism of d-lactate has not been investigated fully.
Normal subjects metabolize d-lactate and d-lactic acid equally well [17, 18] despite the fact that the former tends to increase the blood pH and the latter decreases it, but differences in blood pH in these experiments were quite modest compared with those observed in patients with clinical dlactic acidosis.
Another mechanism by which renal dysfunction might alter d-lactate metabolism is interference with its renal excretion. The renal threshold for d-lactate is low and the renal fractional excretion is very high [52] . Impaired renal function or volume depletion may decrease renal excretion of d-lactate and thereby increase plasma levels.
The suggestion has been made that thiamine deficiency played a contributory role in the pathogenesis of d-lactic acidosis in 1 patient [36] because d-lactic acidosis did not recur after initiation of thiamine supplementation. However, thiamine deficiency has not been shown to increase production of d-lactate when an specific enzymatic method has been used to measure this compound [70] .
On the basis of the available evidence we believe that the development of d-lactic acidosis requires the following conditions: 
Mechanisms of neurologic manifestations
Two main hypotheses have been proposed to explain the neurologic manifestations of the syndrome: 1) d-lactate itself is toxic to the brain, and 2) unknown compounds produced along with d-lactate are toxic to the brain. Indeed, compounds such as formate, histamine, ethanol, tyramine, and endotoxin have been found in the rumen of cattle with d-lactic acidosis [22] , and excessive urinary excretion of hydroxyphenyllactic and phenylacetic acids [8] has been observed in patients with this condition. The role that each of these compounds may play in causing the neurologic abnormalities is uncertain but it is clear that ethanol is not responsible for the symptoms. Although the patients appear drunk, serum levels of ethanol have been normal. D-lactate can penetrate into the central nervous system by simple diffusion and can thus reach high concentrations in the brain [43] . Although it has been hypothesized that d-lactate may accumulate in the brain because of the low local level of catabolizing enzyme [51] , levels of dlactate in the cerebrospinal fluid have been found to be equal to those in the blood [40, 61] .
Moreover, the correlation between plasma d-lactate levels and severity of symptoms is poor.
Thurn et al [66] found that 16 of 33 patients with jejunoileal bypass reported symptoms consistent with d-lactic acid encephalopathy but only 9 of them had high plasma levels of d-lactate, while some individuals with high plasma d-lactate levels did not have symptoms. The fact that some patients present with encephalopathy but without high plasma d-lactate levels strengthens the suggestion that the encephalopathy results from toxins which may be produced simultaneously with d-lactic acid. A further argument against a direct role for d-lactate in the alteration of mental status is that normal subjects who received an infusion of d-lactate did not develop any neurologic symptoms despite the attainment of serum levels up to 6 mmol/L in 1 study [52] and up to 3.5 mmol/L in another study [17] .
Acidosis itself is not likely to be responsible for the neurologic manifestations since patients with other types of acidosis of comparable or greater severity do not present such manifestations.
It could be argued, however, that the abnormal pH might have some role in the toxic effect of dlactate or other chemicals in the brain since patients with d-lactic acidosis usually have significant metabolic acidosis. It is also probable that d-lactate is harmful to the central nervous system only in the presence of another metabolic defect, such as deficiency of certain vitamins, which might be present in patients who develop the syndrome but not in others [15] . Interference on pyruvate metabolism by d-lactate has been postulated based on observation of clinical similarities between d-lactic acidosis and inherited or acquired abnormalities of pyruvate metabolism [15] .
Diagnosis
Increased anion gap and rapid onset and recovery are characteristic features in d-lactic acidosis as in other organic acidosis. However, the critical elements that raise suspicion of this diagnosis in a patient with acidosis are 1) increased serum anion gap with normal lactate levels measured by conventional techniques and negative Acetest, 2) presence of short bowel syndrome or other forms of malabsorption syndrome, 3) acidosis that is preceded by food ingestion and that improves after discontinuation of oral intake of food, and 4) characteristic neurologic findings. syndrome [3, 5, 66] but it is unlikely to be the cause of an associated acidosis. D-lactate is measured enzymatically using a specific d-lactic dehydrogenase in the assay [51] ; kits to measure d-lactic acid in serum and urine can be obtained from Boehringer Mannheim, (Indianapolis, IN) and can be adapted easily to any clinical laboratory. While waiting for the results of these measurements, the patient should receive no food by mouth and should be given intravenous dextrose solutions as a source of calories; the rapid improvement of acidosis on this regimen is highly suggestive of the diagnosis of d-lactic acidosis.
Titration of an increased amount of organic anions in the urine may be an important clue that suggests this diagnosis [51] , but unfortunately this measurement is not available in commercial clinical laboratories.
Modalities of treatment
Treatment modalities that have been tried can be grouped into the following categories and are described in detail in Table 5 : 1) attempts to alter the abnormal intestinal flora with the administration of oral antibiotics and recolonization of the intestine by the oral administration of a bacterial flora called "Julia flora" [60] ; 2) attempts to diminish the quantity of substrate for intestinal fermentation by prolonged oral fasting with simultaneous intravenous alimentation [40, 54, 64] , use of low-carbohydrate diets, or use of enteral formulas containing fructose or starch instead of glucose as the main source of carbohydrates [46, 58] ; 3) correction of the underlying abnormality by reanastomosis of the intestine in case of intestinal bypass [16, 35] ; 4) nonspecific therapy of acidosis with high doses of bicarbonate [6, 46] ; and 5) correction of acidosis and simultaneous clearance of dlactate with hemodialysis [33] .
No large series from a single institution has been reported, and most of the therapeutic modalities are based on the experience of individual practitioners with only 1 or 2 cases with variable success. The most effective immediate treatment consists of elimination of all oral intake of food while providing intravenous nutrition. Long-term management consists of carbohydrate restriction and suppression of the intestinal flora with nonabsorbable antibiotics.
Antibiotics control symptoms and prevent recurrences of the syndrome in most patients, but in some patients acidosis has recurred despite their continuous use [36] , and in others the syndrome may have been precipitated by the use of antibiotics [13] . Therapy with antibiotics has been complicated by the development of diarrhea [55] or unspecified side effects [31] . Antibiotics that have been tried include neomycin, vancomycin, ampicillin, kanamycin, and metronidazole.
The optimum duration of antibiotic therapy is unclear since symptoms may recur a few days after discontinuation of antibiotics in some patients, while others may remain without symptoms after several years without therapy.
Summary
This report describes a case of d-lactic acidosis observed by the authors and then reviews all In contrast to the initial assumption that d-lactic acid is not metabolized by humans, analysis of published data shows a substantial rate of metabolism of d-lactate by normal humans.
Estimates based on these data suggest that impaired metabolism of d-lactate is almost a prerequisite for the development of the syndrome.
